In humans, several small cohort studies revealed a significant increase in circulating chemerin levels in individuals fulfilling MetS criteria [54,55,56], and this significance persisted even after adjusting for waist circumference or BMI, since obesity itself is known to increase chemerin levels [57]. Here, RARRES2 is linked to metabolic syndrome.